Back to Agenda
Labeling as a Strategic Asset: Advancing Patient Voice and Creating Value Through Meaningful Product Communication
Session Chair(s)
Julie Guery, PHD
Global Regulatory Affairs Labeling Head
Sanofi, United States
Explore how patient-focused principles can transform product labeling into a strategic asset. Learn how to integrate patient perspectives early, align with regulatory trends, & leverage labeling to support decision-making and differentiate products.
Learning Objective : Identify opportunities to incorporate patient experience data into product labeling that aligns with FDA/EMA guidance; Examine case studies of successful patient-centered labeling that supports decision-making; Outline approaches to develop labeling strategies that bridge regulatory requirements with patient value.
Have an account?